Streetbeat News

Price Targets

SPIR

Raymond James analyst Ric Prentiss has maintained an 'Outperform' rating on Spire Global (NYSE:SPIR) but lowered the price target from $28 to $27.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 8:12 am

ASO

Telsey Advisory Group analyst Joseph Feldman has reiterated an 'Outperform' rating on Academy Sports (NASDAQ:ASO) and maintained a $72 price target.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 8:09 am

DG

Telsey Advisory Group analyst Joseph Feldman has downgraded Dollar Gen (NYSE:DG) from Outperform to Market Perform and lowered the price target from $185 to $145.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 8:08 am

ALLT

Needham analyst Alex Henderson has reiterated a 'Buy' rating on Allot (NASDAQ:ALLT) and maintained a price target of $4.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 8:07 am

CGNX

Needham analyst James Ricchiuti has reiterated a 'Buy' rating on Cognex (NASDAQ:CGNX) and maintained a price target of $55.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 8:06 am

CIEN

Needham analyst Alex Henderson maintains a Buy rating on Ciena (NYSE:CIEN) and raises the price target from $50 to $60.

Portfolio Pulse from Benzinga Newsdesk

September 01, 2023 | 8:05 am

WMS

Oppenheimer analyst Bryan F. Blair has reiterated an Outperform rating on Advanced Drainage Systems, Inc. (NYSE:WMS), raising the price target to $148 from $140. Blair highlighted the company's expanding partnerships and relationships with top homebuilders, broadening economic moats, and substantial earnings potential. The analyst expects revenues of $2.8 billion and an adjusted EPS of $5.72 for FY24, and revenues of $3 billion and an adjusted EPS of $6.30 for FY25.

Portfolio Pulse from Nabaparna Bhattacharya

August 31, 2023 | 7:03 pm

THG

BMO Capital Markets analyst Michael Zaremski has upgraded The Hanover Insurance Group Inc (NYSE:THG) to Outperform from Market Perform rating with a price target of $126.00. The analyst expects the company's ROE to revert closer to 13% following a series of disappointing quarters. Zaremski also expects THG to witness a decline in policy growth in the coming 18 months. The analyst raised the EPS estimate to $11.53 for FY24 and $13.25 for FY25.

Portfolio Pulse from Lekha Gupta

August 31, 2023 | 7:00 pm

CIVI

BMO Capital Markets analyst Phillip Jungwirth initiated coverage on Civitas Resources Inc (NYSE:CIVI) with an Outperform rating and a price target of $95.00. The analyst expects the company's fundamentals to improve due to a more favorable operating environment and higher oil prices through 2025. The company's recent foray into the Permian basin is expected to boost asset quality and drive diversification. The analyst also expects CIVI's free cash flow to remain strong in 2024 and leverage to reduce following the Tap Rock and Hibernia acquisitions.

Portfolio Pulse from Lekha Gupta

August 31, 2023 | 5:48 pm

MLTX

SLRN

UCBJF

UCBJY

Needham has initiated coverage on MoonLake Immunotherapeutics (NASDAQ:MLTX) with a Buy rating and a price target of $76. The company's lead product, sonelokimab (SLK), is seen as a potential best-in-class treatment for chronic dermatological ailments, outperforming established biologics. The market opportunity for SLK is estimated at $30 billion, expected to grow to $40-$50 billion by the mid-2030s. Needham sees UCB SA's (OTC:UCBJY) (OTC:UCBJF) bimekizumab and izokibep by Acelyrin Inc (NASDAQ: SLRN) as the main competitors to SLK.

Portfolio Pulse from Vandana Singh

August 31, 2023 | 5:38 pm